Christopher Mutz, Head of Rare Disease: Ani Pharmaceuticals ANIP Sell · Filed 24/05/22

Trade details

Type: Insider sale
Amount: $123,220
Shares · price: 2,000 sh · $61.61 a share
Held after: 83,277 sh
Stock: Ani Pharmaceuticals ANIP
Person: Christopher MutzHead of Rare Disease
Trade date: 24/05/21
Filed: 24/05/22
Days to filing: 1 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Ani Pharmaceuticals trades, last 26 weeks

What else happened in Ani Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/21~24/06/20

Christopher Mutz's recent trades

Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$226.5K
3,162 sh
$226.5K
Filed 03/13
Traded 03/13
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$267.2K
3,602 sh
$267.2K
Filed 03/10
Traded 03/09
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$157.4K
2,121 sh
$157.4K
Filed 03/10
Traded 03/06
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$30.9K
417 sh
$30.9K
Filed 03/04
Traded 03/02
Christopher MutzHead of Rare Disease
Sell10b5-1 planAni Pharmaceuticals
Sell10b5-1 plan
Ani Pharmaceuticals
ANIP
$415.3K
5,323 sh
$415.3K
Filed 02/23
Traded 02/20